GO:1900827 positive regulation of membrane depolarization during cardiac muscle cell action potential: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900827 describes any process that activates or increases the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
• The upstroke of the cardiac action potential is driven by voltage-gated sodium channels, principally Nav1.5 (SCN5A), whose subcellular distribution and gating determine depolarization kinetics.
• Calmodulin-dependent kinase II (CaMKII) is functionally targeted to the action potential plateau and regulates L-type Ca2+ current, thereby shaping depolarization and repolarization.
• Ryanodine receptor type 2 (RyR2) activation by Epac inhibits sodium currents in atrial and ventricular cardiomyocytes, providing a direct link between Ca2+ handling and depolarization.
• Potassium channels such as HERG (KCNH2) and KCNA10 modulate membrane potential and can alter the depolarization threshold and action potential waveform.
• Pharmacological and ion-channel modulators, including gabapentin and cobalt/lanthanum, differentially affect cardiac calcium and potassium currents, offering experimental tools to probe depolarization.
Description
GO:1900827, positive regulation of membrane depolarization during cardiac muscle cell action potential, is a biological process term that captures any mechanism that activates or increases the frequency, rate or extent of the depolarization phase of the cardiac action potential. In the heart, the action potential is initiated by a rapid influx of sodium ions through voltage-gated sodium channels, and the precise regulation of this depolarization is essential for normal cardiac excitability and conduction. Disruption of the molecular players that control this process can lead to arrhythmias and other cardiac pathologies, making this GO term a focal point for cardiovascular research. The depolarization phase is not a simple switch; it is fine-tuned by a network of ion channels, kinases, and calcium-handling proteins. For example, Ca2+/calmodulin-dependent kinase II (CaMKII) is targeted to the action potential plateau and regulates L-type Ca2+ current, which in turn influences the duration and amplitude of depolarization. Similarly, Epac-mediated activation of ryanodine receptor type 2 (RyR2) inhibits sodium currents in both atrial and ventricular murine cardiomyocytes, demonstrating cross-talk between calcium release and depolarization. These findings underscore that positive regulation of depolarization is an integrated, dynamic process. Understanding GO:1900827 is important for researchers because it provides a framework to study how genetic variants, pharmacological agents, and disease states alter cardiac electrical activity. For instance, altered gating of HERG potassium channels by cobalt and lanthanum affects membrane potential, and gabapentin differentially modulates neuronal and muscle calcium currents. By focusing on this GO term, scientists can systematically dissect the contributions of individual genes and pathways to cardiac depolarization, ultimately informing therapeutic strategies for arrhythmias and heart failure.
positive regulation of membrane depolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:1900827 |
|---|---|
| GO term | positive regulation of membrane depolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | activation of membrane depolarization during cardiac muscle cell action potential; up regulation of membrane depolarization during cardiac muscle cell action potential; up-regulation of membrane depolarization during cardiac muscle cell action potential; upregulation of membrane depolarization during cardiac muscle cell action potential |
| Major function | Enhances the depolarization phase of the cardiac action potential, primarily by increasing sodium influx and modulating ion channel activity. |
| Related cellular component | Sarcolemma, voltage-gated sodium channel complex, T-tubules, intercalated discs. |
| Related molecular function | Voltage-gated sodium channel activity, calmodulin-dependent protein kinase activity, calcium channel activity. |
| Key regulators | SCN5A (Nav1.5), CaMKII, RyR2, HERG (KCNH2), KCNA10. |
| Disease relevance | Arrhythmias, Brugada syndrome, long QT syndrome, heart failure. |
What Is GO:1900827?
According to the QuickGO definition, GO:1900827 refers to any process that activates or increases the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. In other words, it encompasses all molecular events that make the depolarization phase of the cardiac action potential happen more often, faster, or to a greater extent. This includes the opening of voltage-gated sodium channels, modulation of channel gating by kinases, and interactions with other ion channels that set the resting membrane potential.
Why Is positive regulation of membrane depolarization during cardiac muscle cell action potential Important in Cell Biology?
GO:1900827 is important because the depolarization phase of the cardiac action potential is the trigger for every heartbeat, and its positive regulation ensures that the heart responds appropriately to physiological demands. Dysregulation of this process can cause life-threatening arrhythmias, and many cardiac drugs target the ion channels and signaling molecules that control depolarization. By studying this GO term, researchers can identify new therapeutic targets and understand how genetic mutations lead to inherited cardiac channelopathies.
• Defines the molecular basis of cardiac excitability and the initiation of the action potential.
• Provides a framework to study inherited arrhythmia syndromes such as Brugada and long QT syndromes.
• Highlights the role of CaMKII in tuning depolarization and repolarization, linking calcium signaling to electrical activity.
• Reveals cross-talk between ryanodine receptor-mediated calcium release and sodium currents, as shown by Epac-induced RyR2 activation.
• Implicates potassium channels like HERG and KCNA10 in setting the membrane potential and modulating depolarization.
• Offers experimental targets for pharmacological modulation, as demonstrated by gabapentin and metal ions affecting calcium and potassium currents.
• Supports the development of gene-based therapies and CRISPR models to correct channelopathies.
• Aids in understanding how metabolic factors such as NAD and ammonia interplay regulate papillary muscle contractility via ion channels.
• Guides the interpretation of genomic variants in SCN5A and other genes associated with sudden cardiac death.
• Enables precision medicine approaches by linking specific molecular defects to depolarization abnormalities.
What Happens During positive regulation of membrane depolarization during cardiac muscle cell action potential?
Initiation of the action potential upstroke
In simple terms: The heart cell rapidly becomes more positive inside due to sodium ions rushing in.
The depolarization phase of the cardiac action potential begins when voltage-gated sodium channels, primarily Nav1.5 encoded by SCN5A, open in response to a threshold stimulus. This allows a rapid influx of sodium ions, causing the membrane potential to rise sharply. The subcellular diversity of Nav1.5, including its distribution in the sarcolemma and intercalated discs, influences the initiation and propagation of depolarization. Positive regulation of this step can occur through mechanisms that increase sodium channel availability or open probability.
Modulation by calcium/calmodulin-dependent kinase II
In simple terms: A kinase enzyme called CaMKII fine-tunes the electrical signals by modifying calcium channels.
CaMKII is functionally targeted to the action potential plateau and regulates L-type Ca2+ current in rabbit cardiomyocytes. This regulation can indirectly affect depolarization by altering the balance of inward and outward currents. Additionally, CaMKII activity is dually regulated by membrane voltage and calcium influx, allowing it to act as a sensor that adjusts channel activity in response to electrical and calcium signals. Thus, CaMKII is a key positive regulator of the depolarization process.
Cross-talk with ryanodine receptor type 2
In simple terms: Calcium release channels in the cell can talk back to sodium channels and change their behavior.
Epac-induced activation of ryanodine receptor type 2 (RyR2) inhibits sodium currents in atrial and ventricular murine cardiomyocytes. This inhibition represents a negative feedback mechanism, but under certain conditions, RyR2 activation can also enhance depolarization by modulating calcium-dependent signaling. The interplay between RyR2 and sodium channels highlights the complexity of positive regulation of depolarization.
Role of potassium channels in setting the membrane potential
In simple terms: Potassium channels help set the resting voltage and can influence how easily the cell depolarizes.
Potassium channels such as HERG (KCNH2) and KCNA10 contribute to the resting membrane potential and action potential repolarization. Altered gating of HERG by cobalt and lanthanum affects membrane potential, while KCNA10 is a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels. By modulating the resting potential, these channels can indirectly regulate the threshold for depolarization and thus the positive regulation of the action potential upstroke.
Pharmacological and metabolic modulation
In simple terms: Drugs and metabolites can change how heart cells depolarize.
Gabapentin differentially affects neuronal and muscle calcium currents, and the interplay between NAD and ammonia regulates papillary muscle contractility via ion channels and exchangers. These examples illustrate that positive regulation of depolarization can be influenced by pharmacological agents and metabolic states, providing experimental handles to study the process.
Key Genes Involved in GO:1900827 positive regulation of membrane depolarization during cardiac muscle cell action potential
The following genes and proteins are central to the positive regulation of membrane depolarization during the cardiac muscle cell action potential, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Encodes Nav1.5, the primary voltage-gated sodium channel responsible for the rapid upstroke of the cardiac action potential. | Mutations cause Brugada syndrome and long QT syndrome; target for antiarrhythmic drugs. |
| CAMK2 | Calcium/calmodulin-dependent kinase II; regulates L-type Ca2+ current and is targeted to the action potential plateau. | Modulates depolarization and repolarization; implicated in arrhythmias and heart failure. |
| RYR2 | Ryanodine receptor type 2; mediates calcium release from sarcoplasmic reticulum. | Epac-induced activation inhibits sodium currents; linked to catecholaminergic polymorphic ventricular tachycardia. |
| KCNH2 | Encodes HERG potassium channel; contributes to repolarization and resting membrane potential. | Altered gating by cobalt and lanthanum affects membrane potential; mutations cause long QT syndrome. |
| KCNA10 | Voltage-gated potassium channel related to CNG channels. | Modulates membrane potential; potential role in cardiac excitability. |
| CACNA1C | Encodes L-type calcium channel Cav1.2; contributes to plateau phase. | Regulated by CaMKII; influences depolarization duration. |
| SCN1B | Beta subunit of voltage-gated sodium channels; modulates Nav1.5 gating. | Mutations linked to Brugada syndrome and epilepsy. |
| SCN2B | Beta subunit of voltage-gated sodium channels. | Modulates sodium current density and kinetics. |
| ANK2 | Ankyrin-B; anchors ion channels to cytoskeleton. | Mutations cause cardiac arrhythmia syndromes. |
| SNTA1 | Syntrophin alpha-1; part of dystrophin-associated protein complex. | Regulates Nav1.5 function; linked to long QT syndrome. |
| CAV3 | Caveolin-3; component of caveolae in cardiomyocytes. | Modulates sodium channel localization and function. |
| GPD1L | Glycerol-3-phosphate dehydrogenase 1-like; regulates Nav1.5 trafficking. | Mutations associated with Brugada syndrome. |
| SCN4B | Beta subunit of voltage-gated sodium channels. | Modulates cardiac sodium current. |
| CALM1 | Calmodulin; calcium sensor that regulates CaMKII and ion channels. | Mutations cause long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. |
| CALM2 | Calmodulin; regulates multiple ion channels. | Mutations linked to cardiac arrhythmias. |
| CALM3 | Calmodulin; regulates ion channel activity. | Mutations associated with long QT syndrome. |
| PRKACA | Protein kinase A catalytic subunit; phosphorylates ion channels. | Modulates sodium and calcium currents; involved in arrhythmias. |
| EPAC1 | Exchange protein directly activated by cAMP; activates RyR2. | Inhibits sodium currents; potential target for arrhythmia therapy. |
How Is positive regulation of membrane depolarization during cardiac muscle cell action potential Regulated?
The positive regulation of membrane depolarization during the cardiac muscle cell action potential is itself tightly regulated by multiple signaling pathways. CaMKII activity is dually regulated by membrane voltage and calcium influx, allowing it to act as a dynamic sensor that adjusts ion channel activity in response to electrical and calcium signals. Epac, a cAMP sensor, activates RyR2, which in turn inhibits sodium currents, providing a feedback mechanism that can limit excessive depolarization. Additionally, protein kinase A (PKA) phosphorylates ion channels and can modulate sodium and calcium currents. Metabolic factors such as NAD and ammonia also influence ion channels and exchangers, thereby affecting contractility and electrical activity. These regulatory layers ensure that depolarization is appropriately tuned to physiological demands.
positive regulation of membrane depolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, long QT syndrome type 3 | Knock-in mouse model with SCN5A mutation; patient-derived iPSC-cardiomyocytes |
| KCNH2 | Long QT syndrome type 2 | Heterologous expression of mutant HERG in HEK293 cells; zebrafish knockout |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | RyR2 knock-in mouse; iPSC-cardiomyocytes with RYR2 mutation |
| CAMK2 | Heart failure, arrhythmias | CaMKII knockout or transgenic mice; AAV-mediated gene delivery |
| CALM1 | Long QT syndrome, CPVT | Calmodulin mutant knock-in mice; CRISPR-edited iPSC-cardiomyocytes |
Cardiac arrhythmias and channelopathies
Dysregulation of the positive regulation of membrane depolarization is directly linked to inherited cardiac arrhythmias. Mutations in SCN5A, the gene encoding Nav1.5, cause Brugada syndrome and long QT syndrome type 3, both of which are characterized by abnormal depolarization and increased risk of sudden cardiac death. Similarly, mutations in KCNH2 (HERG) lead to long QT syndrome type 2, where altered potassium channel gating prolongs repolarization and can trigger arrhythmias. These channelopathies highlight the clinical importance of understanding the molecular mechanisms that control depolarization.
Heart failure and metabolic remodeling
In heart failure, changes in ion channel expression and function contribute to altered depolarization and increased arrhythmia susceptibility. The interplay between NAD and ammonia regulates papillary muscle contractility via ion channels and exchangers, suggesting that metabolic remodeling can impact electrical activity. CaMKII overactivity is also implicated in heart failure, where it disrupts calcium handling and promotes arrhythmias. Thus, targeting the positive regulation of depolarization may offer therapeutic benefits in heart failure.
Catecholaminergic polymorphic ventricular tachycardia (CPVT)
CPVT is a genetic disorder caused by mutations in RYR2 or calmodulin genes, leading to excessive calcium release during exercise or stress. Epac-induced RyR2 activation inhibits sodium currents in cardiomyocytes, and this cross-talk may contribute to the arrhythmogenic substrate in CPVT. Understanding how RyR2 modulation affects depolarization could reveal new treatment strategies for this devastating disease.
From positive regulation of membrane depolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific SCN5A variant alter depolarization kinetics? | Point-mutation knock-in in iPSC-cardiomyocytes or mouse |
| What is the role of CaMKII in regulating L-type Ca2+ current during the action potential? | CaMKII knockout or overexpression in rabbit cardiomyocytes |
| How does RyR2 activation affect sodium current? | RyR2 knockout or Epac agonist treatment in murine cardiomyocytes |
| Can a potassium channel modulator rescue abnormal depolarization? | Overexpression of KCNA10 or HERG in heterologous cells |
| What is the subcellular localization of Nav1.5 in disease? | Tagged knock-in of SCN5A with fluorescent protein in cardiomyocytes |
| Does a metabolic factor influence depolarization? | NAD/ammonia modulation in papillary muscle preparations |
How to Study the positive regulation of membrane depolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potential duration, depolarization rate, ion currents | Functional validation of ion channel mutations |
| Calcium imaging | Intracellular calcium transients | Assessing calcium handling in cardiomyocytes |
| CRISPR/Cas9 knockout | Loss-of-function effects of a gene | Determining if a gene is required for depolarization |
| CRISPR point mutation | Effect of a specific variant | Modeling inherited channelopathies |
| CRISPR knock-in reporter | Subcellular localization of a protein | Tracking Nav1.5 trafficking in live cells |
| RNA sequencing | Gene expression changes | Identifying compensatory ion channel regulation |
| Phosphoproteomics | Kinase substrate phosphorylation | Mapping CaMKII signaling to ion channels |
| Optogenetics | Light-controlled ion channel activity | Precise temporal control of depolarization |
Patch-clamp electrophysiology
Patch-clamp recordings are the gold standard for measuring action potentials and ion currents in cardiomyocytes. This technique can quantify the rate and extent of depolarization, as well as the effects of genetic mutations or pharmacological agents on sodium, calcium, and potassium currents. It is essential for validating findings from CRISPR-edited cells.
Calcium imaging and optogenetics
Calcium imaging using fluorescent indicators allows real-time monitoring of intracellular calcium transients, which are tightly linked to depolarization. Optogenetic tools can selectively stimulate or inhibit specific ion channels to dissect their contributions to the action potential. These methods complement electrophysiology by providing spatial and temporal resolution.
CRISPR/Cas9 genome editing
CRISPR/Cas9 enables precise modification of genes involved in depolarization, such as SCN5A, KCNH2, and RYR2. Knockout, point mutation, and knock-in models can be generated in iPSC-cardiomyocytes or animal models to study the causal role of specific variants. This approach is powerful for modeling channelopathies and testing therapeutic strategies.
Transcriptomics and proteomics
RNA sequencing and mass spectrometry-based proteomics can identify changes in ion channel expression and post-translational modifications that affect depolarization. For example, CaMKII-dependent phosphorylation of L-type calcium channels can be detected by phosphoproteomics. These omics approaches provide a systems-level view of the regulatory network.
How CRISPR Can Be Used to Study GO:1900827 positive regulation of membrane depolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of genes such as SCN5A or KCNH2 in cardiomyocytes can abolish or severely reduce depolarization, confirming their essential roles. For example, knockout of SCN5A eliminates the rapid sodium current, providing a clean background to study other contributors. Knockout models are also useful for identifying compensatory mechanisms.
Point Mutation
Introducing disease-associated point mutations (e.g., SCN5A variants found in Brugada syndrome) into the genome allows researchers to study their effects on depolarization kinetics in an isogenic background. This approach has been used to model long QT syndrome and CPVT. Point mutation models are critical for understanding genotype-phenotype relationships.
Knock-in
Knock-in of fluorescent tags or reporter genes into endogenous loci (e.g., SCN5A-GFP) enables real-time tracking of channel trafficking and localization. This is particularly valuable for studying the subcellular diversity of Nav1.5 in cardiomyocytes. Knock-in models can also be used to express mutant proteins under native regulatory control.
Overexpression
Overexpression of ion channels or signaling molecules (e.g., CaMKII, KCNA10) in cardiomyocytes or heterologous systems can enhance depolarization and reveal gain-of-function effects. For instance, overexpression of KCNA10 modulates membrane potential, and CaMKII overexpression alters L-type calcium current. Overexpression studies help establish sufficiency.
How EDITGENE Supports positive regulation of membrane depolarization during cardiac muscle cell action potential Research
Researchers studying positive regulation of membrane depolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. This requires precise genetic models that can isolate the contribution of a single gene or variant. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of membrane depolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About positive regulation of membrane depolarization during cardiac muscle cell action potential
What is GO:1900827?
GO:1900827 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
What genes are involved in positive regulation of membrane depolarization during cardiac muscle cell action potential?
Key genes include SCN5A (Nav1.5), CAMK2, RYR2, KCNH2 (HERG), KCNA10, and various auxiliary subunits such as SCN1B and ANK2.
How does CaMKII regulate cardiac depolarization?
CaMKII is targeted to the action potential plateau and regulates L-type Ca2+ current, thereby influencing depolarization and repolarization.
What is the role of Nav1.5 in the cardiac action potential?
Nav1.5, encoded by SCN5A, is the primary voltage-gated sodium channel that mediates the rapid upstroke of the cardiac action potential.
How do mutations in SCN5A cause disease?
Mutations in SCN5A can cause Brugada syndrome and long QT syndrome type 3 by altering sodium channel function and depolarization kinetics.
Can CRISPR be used to study cardiac depolarization?
Yes, CRISPR knockout, point mutation, and knock-in models in cardiomyocytes or iPSCs are powerful tools to dissect the genetic basis of depolarization.
What experimental models are used to study GO:1900827?
Common models include patch-clamp electrophysiology in isolated cardiomyocytes, iPSC-derived cardiomyocytes, and genetically modified mouse lines.
How does RyR2 activation affect sodium currents?
Epac-induced activation of RyR2 inhibits sodium currents in atrial and ventricular murine cardiomyocytes, demonstrating cross-talk between calcium release and depolarization.
What diseases are associated with abnormal cardiac depolarization?
Diseases include Brugada syndrome, long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and heart failure.
What services does EDITGENE offer for studying this GO term?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services to study genes involved in cardiac depolarization.
Conclusion
GO:1900827, positive regulation of membrane depolarization during cardiac muscle cell action potential, is a critical biological process that governs cardiac excitability. The integration of voltage-gated sodium channels, calcium-handling proteins, and signaling kinases ensures that the heart beats efficiently and adapts to changing demands. Disruption of this process leads to severe arrhythmias and heart failure, making it a prime target for research and therapeutic intervention. By leveraging CRISPR-based models and advanced electrophysiological methods, scientists can unravel the molecular details of this process and develop new treatments for cardiac disease.
References
- 1. Marchal GA et al.. 2023. Subcellular diversity of Nav1.5 in cardiomyocytes: distinct functions, mechanisms and targets.. J Physiol 601(5):941-960 PMID: 36469003
- 2. Averin AS et al.. 2022. Regulation of Papillary Muscle Contractility by NAD and Ammonia Interplay: Contribution of Ion Channels and Exchangers.. Membranes (Basel) 12(12) PMID: 36557146
- 3. Xiao RP et al.. 1994. Dual regulation of Ca2+/calmodulin-dependent kinase II activity by membrane voltage and by calcium influx.. Proc Natl Acad Sci U S A 91(20):9659-63 PMID: 7937825
- 4. Valli H et al.. 2018. Epac-induced ryanodine receptor type 2 activation inhibits sodium currents in atrial and ventricular murine cardiomyocytes.. Clin Exp Pharmacol Physiol 45(3):278-292 PMID: 29027245
- 5. Wu Y et al.. 2004. Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes.. J Physiol 554(Pt 1):145-55 PMID: 14678498
- 6. Lang R et al.. 2000. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.. Am J Physiol Renal Physiol 278(6):F1013-21 PMID: 10836990
- 7. Alden KJ et al.. 2001. Differential effect of gabapentin on neuronal and muscle calcium currents.. J Pharmacol Exp Ther 297(2):727-35 PMID: 11303064
- 8. Sanchez-Chapula JA et al.. 2000. Altered gating of HERG potassium channels by cobalt and lanthanum.. Pflugers Arch 440(2):264-74 PMID: 10898527
